| 2006
Annual Spring Meeting to Emphasize Molecular Imaging
The
2006 CCSNM Annual Spring Meeting will be held March 24-26, 2006,
at the Radisson Hotel City Centre in Indianapolis, Indiana. The
program is titled Nuclear Medicine 2006: Advances and Applications
in Molecular Imaging. James Fletcher, MD, Indiana University
School of Medicine is chairing the local program committee with
Paul Reaume, CNMT, St. John Macomb Hospital in Warren, Michigan
and Ed Wroblewski, DABSNM, St. Vincent’s Hospital in New
Castle, Indiana serving as co-chairs. Watch your mail, email and
the Chapter’s web site for detailed information and on-line
registration. The preliminary program includes the following:
Friday, March 24, 2006
-
7:30 - 8:30 am: Registration and Continental Breakfast in
the Exhibit Area
-
8:30 - 8:35 am: Introduction
-
8:30 - 9:30 am: James Quinn Lecture: Automation in PET Radiochemistry
and Imaging; Timothy R. Degrado, PhD
-
9:30 - 10:15 am: Advances in Molecular Imaging of the Central
Nervous System; Michael D. Devous, Sr. PhD
-
10:15 - 10:45 am: Refreshment Break in the Exhibit Area
-
10:45 - 11:30 am: Advances in Molecular Imaging of Cardiovascular
Disease; Robert J. Gropler, MD
-
11:30 am - 1:00 pm: Lunch on your Own
-
1:00 - 1:45 pm: Advances in Molecular Imaging of Cancer;
Michael M. Graham, MD, PhD
-
1:45 - 2:30 pm: Proffered Papers
-
2:30 - 3:00 pm: Refreshment Break in the Exhibit Area
-
3:00 - 4:00 pm: Software Approaches to Quantify Regional
Brain Activity; Daniel H. Silverman, MD, PhD
-
4:00 - 5:00 pm: Read With The Experts – Cardiac Cases;
Robert J. Gropler, MD
-
6:30 - 8:00 pm: Networking Reception
Saturday, March 25, 2006
-
7:30 - 8:00 am: Registration and Continental Breakfast in
the Exhibit Area
-
8:00 - 9:00 am: Mark Groch Memorial Lecture: The Role of
PET Molecular Imaging in Drug Development
Speaker TBD
-
9:00 - 10:00 am: Models for Translational Research in Nuclear
Medicine and PET; Gary D. Hutchins, PhD
-
10:00 - 10:30 am: Refreshment Break in the Exhibit Area
-
10:30 - 11:15 am: Proffered Papers
-
11:15 am - 12:00 pm: PET/CT Dual Modality Imaging –
A Win or Loss for Nuclear Medicine; James W. Fletcher, MD
-
12:00 - 1:30 pm: Business/Awards Lunch in the Exhibit Area
(Optional)
-
1:30 - 2:15 pm: Future Requirements for Educational Programs
in Nuclear Medicine and Nuclear Medicine Technology; Michael
M. Graham, MD, PhD; Edward E. Wroblewski, MA, DABSNM
-
2:15 - 3:00 pm: Washington Update; Valerie R. Cronin, CNMT,
FSNMTS
-
3:00 - 3:30 pm: Refreshment Break in the Exhibit Area
-
3:30 – 4:15 pm: Molecular Imaging Using SPECT/CT; James
N. Kritzman, BS,RT(N), CNMT
-
4:15 - 5:15 pm: Read with the Experts: Brain Imaging Cases;
Michael D. Devous, Sr. PhD
Sunday, March 26, 2006
-
8:00 - 8:30 am: Continental Breakfast
-
8:30 - 9:15 am: Protocols for Contrast Enhancement in Dual
Modality Imaging; Mark Tann, MD
-
9:15 - 10:00 am: Imaging of Atheromatous Plaques in Coronary
Heart Disease; H. William Strauss, MD
-
10:00 - 10:15 am: Refreshment Break
-
10:15 - 11:00 am: PET/CT – Combined Criteria for Evaluation
of Response to Therapy; Paul D. Shreve, MD
-
11:00 - 11:45 am: Read With The Experts –Oncology Cases;
Steven M. Westphal, MD
Back
to Top
Call
for Abstracts for 2006 CCSNM Annual Spring Meeting
March 24-26, 2006 - Radisson Hotel City Centre
Indianapolis, Indiana
DEADLINE: January 6, 2006
The
Program Committee of the Central Chapter of the Society of Nuclear
Medicine is soliciting abstracts for papers to be presented at
the 2006 Annual Spring Meeting of the CCSNM, to be held March
24-26, 2006 at the Radisson Hotel City Centre in Indianapolis,
Indiana.
Abstracts must be submitted online. The abstract instructions
and submission form may be accessed through the CCSNM web site
(http://www.ccsnm.org).
Awards may also be presented to residents, basic scientist trainees,
technologists and students as noted below. The deadline for submission
is Friday, January 6, 2006.
Who May Submit Abstracts
The Program Committee invites original contributions in nuclear
medicine from both members of the SNM and non-members.
Acceptance Criteria
The abstract must be submitted in the final format and not represent
a work-in-progress. Abstracts that have been presented at any
national or international meeting will not be considered.
CCSNM Awards
Abstracts can be considered for 4 awards.
-
Best Technologist Paper-CCSNM-TS (oral presentation
only) $250. Senior author must be a technologist SNM member.
A $750 educational grant may be awarded to the top-scoring
author if this abstract is also accepted for presentation
at the next SNM annual meeting.
-
W. H. Beierwaltes Award (oral presentation
only) $250. Senior author must be a resident or basic scientist
trainee.
-
Best Technologist Paper-CCSNM (oral presentation
only) $250. Senior author must be a technologist SNM member.
-
Best Student Papers-CCSNM-TS (oral presentation
only) $200, $150, $100.
Author must be a student SNM member. $200 is awarded for the
1st place presentation, $150 for 2nd place and $100 for 3rd place.
If you have any questions, please contact the CCSNM Office at
630-323-7028 or email info@ccsnm.org.
Back
to Top
Nuclear
Medicine – What’s in a Name
By Rebecca Sajdak, BA, CNMT, RT(N)
2005-06 Technologist Section President
With the Central Chapter completing its 50th anniversary year,
it is an appropriate time to recall the historical account of
how the name, “Nuclear Medicine,” was conceived.
This following is an excerpt from the January, 1984 issue of
the Journal of Nuclear Medicine, Vol.25, Number1, pp132-133.
“ The designation that defines our specialty, “Nuclear
Medicine” is the only one known to many and its origin known
to only a few. The terminology that described the application
of radioactive materials to diagnostic and therapeutic medicine
evolved over a number of years and included many names.
Early on, the navy referred to it as “Atomic Medicine,”
but the association with warfare made the name unacceptable. The
Oak Ridge group coined the term “Isotope Medicine,”
but, as R.R. Newell noted, all medicinals, diagnostic or therapeutic,
are composed of isotopes. Robert Ball wished to call it “Radiology”
since the only G-M tube available to him was in the radiology
department. Sam Seidlin objected and proposed “Isotopology.”
The use of the term “radioisotopes” probably originated
from Oak Ridge by way of Paul Aebersold, whose Isotope Division
was the early source of radionuclides. He learned the terminology
at Berkeley while working with E.O. Lawrence, who, in turn, suggested
“radioisotopes” from Joliot-Curie”s article
(1934).
Although “radioisotopes” became a common term at
that time, one person disagreed, Jeff Holter. His dissension was
supported by Gross’s objections that these “isotopes”
were nuclear and not chemical and on Truman Kohman’s proposal
that a “nuclide” is any atomic species characterized
by its protons and neutrons. William Sullivan, a former student
of Fajan’s, adopted the terms “nuclides” and
“radionuclides” for his compilation of the Trilinear
Chart of Nuclear Species. Although the term “radioisotopes”
was used well into the 1960’s to describe the products,
laboratories, and medical practice, the suggestion by Jeff Holter
to use the term “Nuclear Medicine,” was adopted by
the organizing members of the Society of Nuclear Medicine (the
first annual meeting was held at the Benjamin Franklin Hotel,
May 29-30, 1954), and has withstood the test of time, becoming
the official designation for the medical application of radionuclides
worldwide.”
Back
to Top
Message
From the President
Nicholas C. Friedman MD
2005-2006 Chapter President
PET/CT vs CT/PET: What’s in Name?
Rebecca Sajdak discusses in this issue the origins of terms commonly
used in Nuclear Medicine. More recently, we are confronted with
SPECT/CT and PET/CT referring to hybrid systems that are the latest
technological feats of medical imaging. There is a certain bias
in the choice of name. The isotope, or “molecular”
part is usually placed first. This confirms that the study is
primarily an isotope study, and the CT is ancillary to it.
I recently attended the Radiological Society of North America
meeting in Chicago. The vast majority of the Nuclear Medicine
posters were on PET, of which most utilized PET/CT. Some of the
posters I found disturbing. There were CT scans, with adjacent
fused PET/CT images. Traditional PET images alone were absent.
This represents a paradigm shift in how we view PET/CT. Is CT
a tool to improve PET in terms of improved patient throughput,
attenuation correction and localization of PET abnormalities?
Or is PET merely a new form of “contrast”, perhaps
the ultimate contrast agent? Showing images of CT scans with adjacent
fused PET/CT images suggests that there are clinicians who subscribe
to the latter view.
So what’s in a name? Is not PET/CT the same as CT/PET?
Are these differences merely semantics? I suspect not. As a nuclear
medicine physician, PET is by far the biggest new modality to
emerge from the research area of Nuclear Medicine in 20 years.
When all the pieces of this fledging technology became a widely
adapted clinical reality, Nuclear Medicine re-emerged in the spotlight
of diagnostic imaging. The addition of CT enhances PET imaging
in many ways, yet for most cases PET alone remains a remarkable
tool without the need for concurrent CT.
Nuclear medicine is faced with many dangers in the sudden shift
to high-end CT scanners attached to PET scan devices. Will the
patient first get a diagnostic CT to go with the PET/CT? Will
the initial CT be dropped to avoid repetitive studies? Who will
read the CT? How will the Nuclear medicine physician face reading
a PET/CT without a prior CT report? These questions make me want
to reach into my desk drawer filled with the latest gastrointestinal
cocktail. Getting PET in the first place required a few bottles
of “TUMS”. Keeping PET in Nuclear Medicine is a challenge
the Nuclear Medicine Community will need to tackle head on, perhaps
armed with the latest proton pump inhibitors.
Back
to Top
Nuclear
Medicine – The Last 30 Years
Robert E. Henkin, MD, FACNP, FACR
Professor Emeritus of Radiology
Loyola University Medical Center
As
I look forward to retiring from active clinical practice I reflect
on the thirty years I’ve spent in nuclear medicine. Actually,
closer to 35 years, but I spent thirty of those years at Loyola.
I entered nuclear medicine just prior to the formation of the
ABNM. Jim Quinn convinced us that there would be an American Board
of Nuclear Medicine and that it was okay to be a nuclear medicine
resident. He assured us that there would be jobs for us and that
there would be a bright future. Strangely enough, I hear the same
reservations today from the nuclear medicine residents that I
heard form our group over thirty years ago. Yet we have had a
successful career, a great run and a good time.
When we took the Hippocratic oath we swore among other things
to render the best patient care we knew how, to do no harm, and
to teach our skills to those who would follow us. There was nothing
in the Hippocratic oath about relative value units, payment classifications
or salary. Further, there is nothing about territorial issues,
about turf battles, nor about anti-trust laws. All of those things
have crept into medicine and have tended to corrupt and undermine
the Hippocratic oath.
One of the most important things to keep in mind is that every
day you spend as a health care professional it is your task to
take care of patients. You should take care of patients the best
way you know how with the best resources you have available. Your
patients deserve the best you can do for them. Sometimes that
involves conflict with your hospital administration or with outside
parties who think they control the quality and payment system.
We are the patient’s advocate. Failure to advocate for your
patients is a violation of your obligation to the patient.
Nuclear medicine is unlike any other medical specialty, it is
a true team approach. Our team includes basic scientists, physicians,
and technologists. However, there is a member of our team that
is rarely recognized. That member is industry. Nuclear medicine
could not exist without its industrial partners. We may have ideas,
we may have protocols, we may have patients, but only the industry
can provide us with the tools to care for the patients. In no
other medical specialty that I have noted does industry play has
such a central and integral role. The failure to recognize the
role of industry in the practice of nuclear medicine will cause
progress to cease. All of the conflicts of interest not withstanding,
a close alliance with industry is important for our future.
People often referred to the time that I entered Nuclear Medicine
as the “Golden Age of Nuclear Medicine.” I don’t
view it that way. I think we are entering the Golden Age of Nuclear
Medicine now. The number of diseases we can successfully treat
and impact is increasing. We have patients surviving today with
various diseases who have failed forms of therapy other than nuclear
medicine. We have bettered patients’ lives who were suffering
in pain and in many cases they can live a normal life until their
disease progresses. We have identified patients at risk of heart
attack and led to interventions that both prolonged their life
and improved the life they lived. In many other instances, we
have discovered life-threatening infections that were not found
by other modalities. Most of the things referred to above were
not possible in the “Golden Age”.
People ask me then “Why are you retiring?” There
is never any one single reason for a person to change the flow
of their career. I am retiring from active clinical practice,
not from life. Neither am I retiring from nuclear medicine. There
are changes in medical practice which are in conflict with my
ethical beliefs about how I can practice as a physician. Some
of them have no resolution at the present time. As long as I am
in clinical practice, I will be unable to deal with some of those
issues. Hopefully, once I leave active clinical practice I will
be able to voice some of those issues clearly and perhaps lead
to some changes with regard to how we care for patients. Organized
nuclear medicine is vital to the continuing growth of our specialty
as well as for our education. I hope to remain active in the chapter
and SNM. I look forward to seeing many of you at future meetings.
I think of all you as part of our larger family of nuclear medicine.
I wish you well in all your endeavors.
Robert E. Henkin, MD, FACNP, FACR
Back
to Top
Technologist
Section Launches High School Outreach Program
To
increase interest in the field of Nuclear Medicine as well as
the number of people entering the field, the CCSNM-TS is establishing
an urban outreach program designed to inform high-school students
of the educational and job opportunities available in the health
sciences, in general, and Nuclear Medicine, in particular. The
program will be designed to have experts in the field give brief
AV presentations to Junior and Senior high school students on
their scheduled career days. Included will be an overview of the
various Nuclear Medicine job positions that exist in the US as
well a brief description of the job responsibilities. In addition,
a short video presentation will include a few Nuclear Medicine
images to give the attendees a sense of some of the technical
aspects of our field as well as the various diseases that it is
possible to diagnose.
“Many high school students in the US have little opportunity
to learn about the job market, especially in the basic sciences”,
reports Rebecca Sajdak, President of the CCSNM-TS. “High
school “job fairs” and “career days” go
a long way toward helping to solve this problem.” Historically,
members of the local scientific community have volunteered their
time to make short, directed presentations in their area of expertise
to these high school students, giving them insight into the exciting
opportunities available to them after they graduate from high
school or college.
Nuclear Medicine is very appealing to those people entering the
work force who are technically inclined. Coupled with the scientific
challenges presented in the field and the prestige of being a
Nuclear Medicine Technologist, Nuclear Medicine offers one of
the highest levels of remuneration among all scientific and medical
technical positions.
This is the opportune time to educate and inform students who
are in the process of deciding what to do with their future. “CCSNM’s
participation will place us in the forefront compared to other
organizations in the field” stated Sajdak.
Objectives of the Outreach program include the following:
-
Provision of community outreach programs to maintain compliance
with the requirements of State and Federal Tax Exempt Status
laws
-
Bring awareness to the community about nuclear medicine technology
-
Communicate the career opportunities available in nuclear
medicine technology and the exciting challenges available.
-
Give high school students information on the location and
length of nuclear medicine technologist programs in their
area, where registration information is available, and each
school’s history in placing graduates in jobs.
-
Communicate information concerning scholarships, grants,
and loans available for college students.
Persons interested in the Outreach Program or being a facilitator
should contact Rebecca Sajdak at rsajdak@lumc.edu.
Back
to Top
Central
Chapter Successfully Re-Launches Fall Educational Program
After a five year hiatus, the Central Chapter successfully re-instated
the Fall Educational Symposium, Fusing Form and Function,
October 1-2, 2005 at the Hilton Mall of American Hotel in Minneapolis,
Minnesota. The day and a half program on the fundamentals and
clinical applications of fused scans was attended by 100 nuclear
medicine physicians and technologists, earning 9.0 credit hours
of CME or VOICE credit from the Society of Nuclear Medicine. The
program, chaired by Robert R. Butler, MD, PhD and Linda L. Laman,
CNMT, combined general information of mutual interest to physicians
and technologists with concurrent sessions specifically designed
for physicians and technologists.
The evaluations rated the program and presentations very high.
Based on the success of the 2005 Fall Educational Symposium, the
Central Chapter is scheduling a Fall Symposium in October 2006
in Traverse City, Michigan. A summary of the 2006 Fall Education
Symposium is included elsewhere in this issue of the newsletter.
 |
 |
A full house listens to the technology track at the
2005 Fall meeting. |
Fall meeting attendees enjoy a refreshment break while
visiting with exhibitors. |
The 2005 program on image fusing included the following topics
and speakers.
Saturday, October 1, 2005
- Fusing Personnel: Update on SNM and ACR Requirements for Physicians
Interpreting Fused Scans,--Gary L. Dillehay, MD
- Training Requirements for Nuclear Medicine, CT and Radiation
Therapy Technologists-- Anne C. Chapman, CNMT, RTR, FSNMTS
- PET Radiopharmacy-- D. Scott Holbrook, BS, CNMT, FSNMTS
- Initial Clinical Experience with SPECT/CT--Donald R. Neumann,
MD, PhD
Clinical Track
- Head and Neck Anatomy & CT Correlations-- Blake A. Carlson,
MD
- Fusion and ENT Perspective-- Robert W. Smith, MD
- Chest: Anatomy and CT Correlations-- Anders M. Knutzen, MD
- Use of PET Scan by Pulmonologists-- Lee M. Kamman, MD
Technology Track
- CT Applications and Procedures for the PET/CT Technologist--
Keith R. Stone, BS, RTR, CT, MR
- X-ray Contrast and Contrast Related Reactions--Jeffrey M.
Barkmeier, MD
- Medical Image Fusion: How it Works-- Linda L. Laman, PET,
CNMT
- Recognizing Drug Induced ECG Abnormalities-- John B. Davis,
MD
Sunday October 2, 2005
- Abdomen and Pelvis: Anatomy and CT Correlations--Subbarao
Inampudi, MD
- Fusion Favors the Prepared Mind-- Robert R. Butler, Jr., MD,
PhD
- Cyberknife Stereotactic Radiosurgery-- Andrew S. Fink, MD
- Fused PET: A Radiation Oncologist’s Point of View--Xin
Wang, MD, PhD
Back
to Top
SNMTS
National Council of Representatives Meeting Report
By Katherine A. Carlson, BA, CNMT, CCRC
The
National Council of Representatives Meeting is a meeting of people
representing the Chapters, industry, education, students, the
Executive Board and the House of Delegates. The NCR has the responsibility
to develop and recommend to the Executive Board, policies and
programs regarding professional issues affecting nuclear medicine
technology. Several issues of importance to the Chapters were
discussed at the NCR meeting, held prior to the 2005 Society of
Nuclear Medicine Annual Meeting.
NMTCB and VOICE
The Educational policy of the NMTCB will become effective January
1, 2006. Voluntary reporting of educational activities began in
2005 with mandatory reporting of required educational activities
in 2006. Certificants are encouraged to review the updated guidelines
for the continuing education policy at www.nmtcb.org. There is
reciprocity between ARRT and NMTCB of continuing education credits.
But this year, ARRT has changed its policy and mandated stricter
verification of attendance at meetings offering continuing education
credit. This change takes effect January 1, 2006. Each attendee
must verify attendance at the start of the educational session
and at the end of the session. The SNMTS finds the ARRT verification
requirement impractical and costly at meetings with large attendance
such as the educational sessions at the SNM annual meeting. The
SNMTS will present their concerns to the ARRT.
The ARRT also tightened requirements for programs to qualify
for continuing education credits (i.e., VOICE). The SNM office
now needs a minimum of 4 weeks to process program applications
for VOICE credit.
The NMTCB Ethics/Disciplinary policy became effective January
1, 2005. Certified Technologists are encouraged to review the
policy on the NMTCB web site (http://www.nmtcb.org).
The NMTCB has 17,974 active certified technologists with 327
having passed the Cardiology specialty exam and 114 passing the
PET certification exam. There are 233 technologists registered
to take the next NCT exam, 193 to take the PET exam [7 are RT(R)],
and 4 to take the PET+NCT exam.
CARE Act
The CARE Act has been reintroduced into the House this session
and the RadCARE Act in the Senate. The SNMTS will call for its
membership to send letters of support to their representatives
in Washington, DC.
Professional Development Task Force
The SNMTS is struggling to meet the requirements of a large and
growing organization with regard to future leadership. A strategy
has been prepared to create a larger leadership pool. The Professional
Development Strategy has three steps:
-
Identify and recruit new leadership candidates.
-
Train new candidates through a Leadership Curriculum.
-
Ongoing evaluation and support of leadership competencies.
Current SNMTS leaders were asked to identify a member with the
potential to become a future leader and to agree to mentor the
candidate. The mentors will report on their candidate’s
progress through Steps 1 and 2 of the Strategy to the SNMTS leadership
at the 2006 MidWinter Meeting.
Education and Research Foundation
In 2005, the ERF provided $99,750 in grants and awards that benefited
130 nuclear medicine and nuclear medicine technologist students,
trainees and professionals in the form of scholarship assistance,
fellowship opportunities, research grant support and recognition
awards. From October 1, 2004 through May 25, 2005, 269 SNM members
contributed $27,284 to the general fund of the ERF and 229 members
contributed $4,208 to the Paul Cole Scholarship Fund. A three-year
fundraiser, “Shaping the Future”, will be launched
later this year. The goal of the plan is to raise $500,000 by
the end of year three to award to the nuclear medicine community.
The recent issue of the SNM Development Office publication, Contributor,
recognized the $2000 contribution from the Central Chapter Technologist
Section to the Paul Cole Scholarship Fund. The contribution will
establish two additional scholarships for students in programs
in the Central Chapter. It is hoped that the Central Chapter’s
lead in establishing scholarships will encourage other Chapters
to make contributions to the ERF.
 |
Past, Present
and future leadership of the Central Chapter Tech Section
network at the annual meeting. Left to right: Lyn Mehlberg,
Past President, CCSNMTS, and SNMTS, Kathy Carlson, Immediate
Past President, CCSNMTS, Rebecca Sajdak, President, CCSNMTS,
Sharon Lafferty, Past President, CCSNMTS, Jim Kritzman,
President-Elect, CCSNMTS, Karen Martin, Past President,
CCSNMTS |
Election Results
The SNMTS Nominating Committee announced the election results
as follows:
-
President-Elect: D. Scott Holbrook
-
Secretary: April Mann
-
Finance Committee: David Gilmore
-
SNM House of Delegates: Kathy Thomas, Danny Basso, Cindi
Luckett-Gilbert and Mary Moreau
The SNMTS awarded Danny Basso and D. Scott Holbrook the distinction
of Fellow of the SNMTS for their service on the Chapter and National
levels of the SNMTS. They may now use the initials FSNMTS after
their names.
Congratulations go to Karen Martin, past president of the Central
Chapter Tech Section, on her election by the NCR as a member-at-large
on the SNMTS Executive Board.
Back
to Top
CCSNM
Fall Education Program Scheduled for Traverse City, Mich.
Following
the great success of the CCSNM’s re-instituted Fall Educational
Program October 1-2, 2005 in Minneapolis, after five years hiatus,
the Chapter is scheduling the 2006 Fall Educational Program in
October, 2006 in Traverse City, Michigan The program, tentatively
titled Functional nuclear imaging: Changing patient management
is being organized by Rick V. Hay, MD and Karen Martin, CNMT.
Watch your mail, email and the CCSNM web site for further information.
The preliminary program is noted below.
Saturday
- 7:30 am: Registration and Continental Breakfast
- 8:00 am: Functional Brain Imaging
- 9:00 am: To SPECT or not to SPECT
- 10:00 am: Patient Preparation for Non-cardiac Procedures
- 11:00 am: Multimodality Imaging and Fusion Techniques
- 12:00 noon: Lunch on your own
- 1:00 pm: Exam Selection and Sequencing for Effective Diagnosis
and Cost Effectiveness.
- 2:00 pm: Radioimmunotherapy—First Line Treatment for
NHL
- 3:00 pm: Seraspheres
Sunday (Emphasis on cardiology)
- 8:00 am: Expanded utilization of cardiac imaging for patient
management
- 9:00 am: Instrumentation.
- 10:00 am: Radiation Safety
- 11:00 am: New Pharmacologic Stress Agents. What is Best for
Your Patient?
Back
to Top
Notes
from the Tech Section
Rebecca
Sajdak, BA, CNMT, RT(N)
2005-06 Technologist Section President
The Central Chapter held its first fall meeting in 5 years in
beautiful Minnesota exploding with the colors of fall foliage,
attracting technologists, physicians, and students with the interesting
topic of Fusing Form and Function. The seminar was a comprehensive
program taking a look at the fundamentals of fusing images. Speakers
covered step by step instruction of how to read multiple modalities
under one umbrella.
Nuclear Medicine is experiencing great growth and influence from
other technologies such as Cyberknife stereotactic radiosurgery
and new radiation therapy techniques such as IMRT which use fusion
to plan a more precise treatment for the patient.
Fusion has a tremendous impact on patient planning and clinical
interpretation. One of the most stimulating points made at this
meeting was that all modalities should compliment each other and
not compete with one another in order to give the patient optimal
care. As the demand on the technologist grows, there is little
time for extra curriculum.
Back
to Top
Technologists
Tips: Proper Injection Techniques
By Rebecca Sajdak, BA, CNMT, RT(N)
When
administering any radioisotope, regardless of the route of administration,
the technologist must do the following:
Do’s
-
Confirm Patient’s identity by two methods: A) Name-have
patient clearly state full name and spelling. B) Birth date
verbally stated by the patient. Inpatients, use identification
bracelet and chart to identify correct patient and test
-
Confirm pregnancy status on females under the age of 55.
-
Confirm correct study, correct isotope & correct amount
of isotope
-
Explain procedure to patient and answer questions prior to
injection
-
Always use aseptic technique to draw dose and ensure fresh
needle is in place for injecting into patient.
-
Place the extremity in a dependent position (lower than the
patient’s heart because gravity slows venous return
and distends the veins).
-
If injecting into an existing line, aseptically swab the
port and then flush With normal saline to ensure patency
-
When preparing isotope to inject, ensure that the preparation
is in accordance with the package insert instructions
-
When performing a tagged red blood cell study, ensure the
blood is placed in a heparinized vacutainer and inverted several
times to insure homogeneity. Use largest gauge needle possible
to re-inject the tagged RBC’s
- Record the dosage, time, route of injection, and any additional
relevant information (i.e., chance of infiltrate, etc.) &
signature. Infiltration of PET doses of F-18 FDG will invalidate
SUV data for that patient.
Don’ts
-
Do not recap needle. If completely necessary to recap, use
the one hand method or needle cap holder
-
Never push air out of syringe once dose is drawn.
-
Do not inject without correct syringe shield for isotope
-
Don’t assume anything. Only inject with syringe that
is labeled with name, study, isotope, date & time
-
When patient has had mastectomy, never inject in arm coinciding
with surgically removed breast; never inject in arm with fistula
present
-
Never inject stannous pyrophosphate (Cold PYP) through any
plastic tubing or existing port (i.e., butterfly, IV line,
fistula, PIC line, heparin lock etc.) Do not inject pertechnetate
in same site as PYP
-
Once a dose has been drawn, never return to a container.
This practice avoids product contamination as well as misadministrations.
-
Do not draw back blood into syringes containing Tc99m MAA.
This can cause clotting of the dose and an altered biodistribution
resulting in difficulty interpreting the scan. If dose is
contaminated with blood, discard the dose and draw a fresh
one.
-
Do not dispose of any radioactive waste (i.e., bandage, gauze)
in regular trash
-
A needle is designed for single use, good for one venipuncture
only, whether it’s the vial or a patient
RULE OF THUMB: When in doubt, Throw it out!!!
Back
to Top
Nuclear
Medicine Pioneer Paul V. Harper, MD Died During the Summer
1915 - 2005
Paul
V. Harper, MD, 89, a pioneer in nuclear medicine, died of pneumonia
and complications from diabetes Friday, July 15, in the Palliative
CareCenter and Hospice of the North Shore in Evanston.
Dr. Harper was born in Chicago and grew up in Libertyville. Though
his grandfather was William Rainey Harper, University of Chicago.'s
first president, Dr. Harper attended Harvard University, where
he majored in biochemical sciences and studied under Dr. George
Wald, who won a Nobel Prize in 1967.
Dr. Harper graduated from Harvard with honors in 1939, the same
year he married the former Phyllis Sweetser. He graduated from
Harvard Medical School in 1941, and moved with his wife to Hyde
Park, where he began a surgical residency at the University of
Chicago.
The residency was interrupted by a three-year tour of duty in
the Army that took him to France in 1944 and 1945. Dr. Harper
returned to the university, where he became an assistant professor
of surgery in 1953, an associate professor in 1955 and a professor
in 1960. He moved his family to Glencoe, but continued spending
most of the week in Hyde Park, said his son William.
As a professor in the surgery and radiology departments at the
university's medical school for more than 40 years, Dr. Harper
pioneered diagnostic and therapeutic uses of radiation that made
him a veritable scientific celebrity in the 1960s. His breakthroughs,
such as the discovery of iodine-125 in 1961, routinely made news.
The university wholeheartedly supported his work, leading Dr.
Harper to decline every offer he had from other schools, even
when the offer came with a raise, Dr. Harper's son said.
He was "incredibly dedicated to his work," his son
said, but he allowed himself hobbies, including judo, playing
the oboe, skiing and rock climbing.
Dr. Harper retired in 1986, becoming a professor emeritus, but
he continued researching until last year.
He is also survived by two daughters, Stephanie and Cynthia;
another son, David; a sister, Jane Overton; and two grandchildren.
This obituary originally appeared in the Chicago Tribune.
Back
to Top
William
H. Beierwaltes, M.D, Chapter Award Honoree Passes
William H. Beierwaltes, MD, a true pioneer in the field of nuclear
medicine, died in August at the age of 88. He attended the first
training course for physicians on the medical use of radioactive
iodine, held at the Oak Ridge National Laboratory in 1946, soon
after radioactive elements first became available for civilian
medical use.
He founded one of the nation's first hospital programs for the
use of radioactivity in medicine. At the University of Michigan,
he opened a clinic for patients with hyperthyroid disease and
thyroid cancer, using radioactive iodine to detect abnormal activity
in the thyroid gland and locate tumors. He later pioneered the
combined use of radioiodine and surgery for therapy of benign
and malignant disease of the thyroid. He was also instrumental
in developing several nuclear medicine agents still in use today.
Dr. Beierwaltes is credited with the original idea to label MIBG
(meta-iodo benzylguanidine) with I-131 (and later I-123) and was
the co-holder of a patent on MIBG, now widely used for identifying
and treating pheochromocytomas and neuroblastomas. I-123 MIBG
has more recently been extensively utilized in the evaluation
of cardiac innervation. In keeping with his endocrinology training,
he also fostered development of I131-iodonorcholesterol, useful
in the diagnosis of adreno-cortical tumors, such as aldosteronomas
and cortisol-producing adenomas.
He was responsible for promoting the profession of Nuclear Medicine.
In 1957 he wrote Clinical Use of Radioisotopes, the first textbook
to fill a gap in the novel field the clinical applications of
radionuclides. He was instrumental in creating one of the first
nuclear medicine fellowship programs in the nation at the University
of Michigan. Beierwaltes is also known as one of the first physicians
to propose radionuclide-labelling of antibodies, a concept that
has led to its widespread use in both imaging and treatment.
An internationally renowned scholar, Beierwaltes wrote or co-authored
during the course of his prolific career 257 peer-reviewed papers,
61 other academic papers, four books, and 77 book chapters and
gave hundreds of presentations at medical society meetings and
other talks.
Born in Saginaw, MI, Dr. Beierwaltes received his bachelor's
degree in 1938 and his medical degree in 1941 at the University
of Michigan in Ann Arbor where he later trained as an endocrinologist.
He soon developed an interest in the new field of nuclear medicine,
after joining the faculty at the University of Michigan Medical
School in 1945. He was appointed to lead the university's new
Clinical Radioisotope Service in 1952, and then later became chief
of the newly created Division of Nuclear Medicine in the early
1960s.
He was the recipient of numerous awards during his long career,
among which were the Society of Nuclear Medicine George de Hevesy
Nuclear Medicine Pioneer Award in 1982 and the American Medical
Association's Scientific Achievement Award in 1994.
He was a fellow of the American Association for the Advancement
of Sciences and the American College of Physicians, served as
president of the Society for Nuclear Medicine in 1965 and was
a longtime member, and was a founding member and distinguished
fellow of the American College of Nuclear Medicine. He was also
a member of the American Association of Physicians.
Throughout his career, Beierwaltes promoted both the scientific
and public knowledge of the profession of nuclear medicine in
its multiple facets, contributing historical milestones in research
and development of radiopharmaceuticals, fostering the professional
development of generations of physicians and technologist, and
setting high standards of professional and technical achievement
through wide dissemination of clinical knowledge and the unrelenting
work in professional organizations, some of which he helped create.
Dr. Beierwaltes helped mold the field of Nuclear Medicine as we
all know it today. In His honor, the Central Chapter instituted
several years ago the W. H. Beierwaltes Award for oral presentations
by residents or basic scientists at the Annual Meeting.
He is survived by his wife of 63 years, Mary-Martha, and by children
Andrew, William Howard and Martha.
To him goes, our perennial gratitude and admiration.
Back
to Top
CC
News Info
CCSNM Mission Statement
Central Chapter of the Society of Nuclear Medicine is an organization
dedicated to promote continued education in the art and science
of nuclear medicine. Through regular meetings and scientific sessions,
members from Minnesota, Wisconsin, Illinois, Michigan, Indiana
and a portion of Ohio are provided the opportunity to not only
review existing technology and methodologies, but also become
familiar with newer techniques, equipment and radiopharma-ceuticals.
In this manner, the members are kept appraised.
Contact Us
Central Chapter – Society of Nuclear Medicine
475 S. Frontage Road, Suite 101
Burr Ridge, IL 60521
Ph: 630-323-7028
Fax: 630-323-6989
Email: info@ccsnm.org
Web Site: www.ccsnm.org
Back
to Top |